Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quidelortho Corp (NQ: QDEL )

38.80 -0.09 (-0.23%)
Streaming Delayed Price Updated: 3:56 PM EDT, Oct 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Quidelortho Corp

< Previous 1 2 3 4 5 6 7 Next >
A Biotech Breakout Will Be Led By Small Caps
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. 
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Cracking The Code: Understanding Analyst Reviews For QuidelOrtho
Via Benzinga
Why QuidelOrtho Stock Blasted 10% Higher Today
The healthcare company has significant and untapped earnings potential, asserts one pundit. 
Via The Motley Fool
G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Analyst Scoreboard: 6 Ratings For QuidelOrtho
Via Benzinga
Why QuidelOrtho Stock Is Crashing Today
The in vitro diagnostics company had a lot of bad news in its Q4 update. 
Via The Motley Fool
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
QDEL Stock Earnings: QuidelOrtho Misses EPS, Beats Revenue for Q1 2024
QDEL stock results show that QuidelOrtho missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
What's Going With COVID-19 Test Maker QuidelOrtho Stock On Tuesday?
QuidelOrtho secures FDA approval for QuickVue COVID-19 test, catering to home and medical settings. Despite Savanna RVP4+ assay withdrawal, company promises a new multiplex assay for 2024/2025... 
Via Benzinga
Exposures COVID-19 Product Safety
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23. 
Via Talk Markets
Recap: QuidelOrtho Q4 Earnings
Via Benzinga
Earnings Preview For QuidelOrtho
Via Benzinga
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. 
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, March 9
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of March 4-8. 
Via Talk Markets
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 17
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Feb. 12-16, 2024. 
Via Talk Markets
Dow Edges Higher; QuidelOrtho Shares Plummet
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.11% to 38,313.27 while the NASDAQ rose 0.70% to... 
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?
The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings. 
Via Benzinga
Topics Economy
Exposures Interest Rates
QuidelOrtho Analysts Cut Their Forecasts After Downbeat Results
QuidelOrtho Corp (NASDAQ: QDEL) posted weaker-than-expected results for its fourth quarter on Tuesday. 
Via Benzinga
Why Is Diagnostic Maker QuidelOrtho Stock Crashing Wednesday?
QuidelOrtho's Q4 2023 EPS at $1.17, below consensus $2.05. Sales: $742.6M, missing estimate $796.91M. Respiratory revenue down 49%. William Blair downgrades to Market Perform. 
Via Benzinga
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Moves Lower; Louisiana-Pacific Posts Upbeat Earnings
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Wednesday. The Dow traded down 0.20% to 38,194.62 while the NASDAQ rose 0.19% to 15,686.43. The S&P... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth- 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news affecting shares on Wednesday morning! 
Via InvestorPlace
US Stocks Priming For Relief Rally After Inflation-Driven Selloff: Strategist Expects To Be Among 'Buyers Of Pullback' Over Next 2-5 Days
The lone piece of Main Street catalyst due for the day is a speech by a supposedly "centrist" Fed official. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Airbnb Reports Q4 Results, Joins MGM Resorts, Upstart And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures trading higher by around 80 points on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Earnings Scheduled For February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.